print
mail
Home
Media
In the News
Amgen and FDA Agree to Modify NplateŽ Risk Evaluation and Mitigation Strategy
Overview
Fact Sheets
Featured Content
Press Releases
Social Media
Media Contacts
In the News
Virtual Press Kits
NplateŽ (romiplostim) in the News
Amgen and FDA Agree to Modify Nplate® Risk Evaluation and Mitigation Strategy
Amgen Press Release
Nplate® REMS
Letter to Healthcare Providers
Letter to Professional Societies
Nplate® Prescribing Information
Prescribing Information and Medication Guide
Related Links
Products
Pipeline
Corporate Citizenship
Locations
footer
